The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants

Biochimica et Biophysica Acta - General Subjects

Volumn 1623, Issue 2-3, 2003, Pages 88-97

  Nakajou, Keisuke ^a   Watanabe, Hiroshi ^a   Kragh Hansen, Ulrich ^b   Maruyama, Toru ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Glycation; Human serum albumin; Organ uptake; Positive charge; Site directed mutagenesis

Indexed keywords

DANSYLSARCOSINE; GLUCOSE; HUMAN SERUM ALBUMIN; MUTANT PROTEIN; SARCOSINE; TRYPTOPHAN; UNCLASSIFIED DRUG; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; GLYCATION; KIDNEY; LIVER; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RAT; ULTRAVIOLET SPECTROSCOPY; YEAST;

EID: 0142138645     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2003.08.001     Document Type: Article

References (39)

1. Peters T. Jr. All About Albumin: Biochemistry, Genetics, and Medical Applications. 1996;Academic Press, San Diego.
2. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-215.
3. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12:1999;439-446.
4. Bourdon E., Loreau N., Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13:1999;233-244.
5. Vorum H., Fisker K., Otagiri M., Pedersen A.O., Kragh-Hansen U. Calcium ion binding to clinically relevant chemical modifications of human serum albumin. Clin. Chem. 41:1995;1654-1661.
6. Shaklai N., Garlick R.L., Bunn H.F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259:1984;3812-3817.
7. Iberg N., Fluckiger R. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J. Biol. Chem. 261:1986;13542-13545.
8. Robb D.A., Olufemi O.S., Williams D.A., Midgley J.M. Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry. Biochem. J. 261:1989;871-878.
9. Chen R.F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242:1967;173-181.
10. Watanabe H., Yamasaki K., Kragh-Hansen U., Tanase S., Harada K., Suenaga A., Otagiri M. In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm. Res. 18:2001;1775-1781.
11. Coussons P.J., Jacoby J., McKay A., Kelly S.M., Price N.C., Hunt J.V. Glucose modification of human serum albumin: a structural study. Free Radic. Biol. Med. 22:1997;1217-1227.
12. Rendell M., Stephen P.M., Paulsen R., Valentine J.L., Rasbold K., Hestorff T., Eastberg S., Shint D.C. An interspecies comparison of normal levels of glycosylated hemoglobin and glycosylated albumin. Comp. Biochem. Physiol. 81B:1985;819-822.
13. Nagai R., Matsumoto K., Ling X., Suzuki H., Araki T., Horiuchi S. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes. 49:2000;1714-1723.
14. Watanabe H., Kragh-Hansen U., Tanase S., Nakajou K., Mitarai M., Iwao Y., Maruyama T., Otagiri M. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J. 357:2001;269-274.
15. Muller N., Lapicque F., Drelon E., Netter P. Binding sites of fluorescent probes on human serum albumin. J. Pharm. Pharmacol. 46:1994;300-304.
16. Maes V., Engelborghs Y., Hoebeke J., Maras Y., Vercruysse A. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. Mol. Pharmacol. 21:1982;100-107.
17. Rajkowski K.M. Comparison of graphical procedures for estimating the intrinsic molar fluorescence of protein-bound drugs for drug-binding studies. A reevaluation of existing plots and introduction of two inverse hyperbolic plots. Biochem. Pharmacol. 39:1990;895-900.
18. Ozeki Y., Kurono Y., Yotsuyanagi T., Ikeda K. Effects of drug binding on the esterase activity of human serum albumin: inhibition modes and binding sites of anionic drugs. Chem. Pharm. Bull. 28:1980;535-540.
19. Kurono Y., Kushida I., Tanaka H., Ikeda K. Esterase-like activity of human serum albumin: VIII. Reaction with amino acid p-nitrophenyl esters. Chem. Pharm. Bull. 40:1992;2169-2172.
20. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature. 194:1962;495-496.
21. Hnatowich D.J., Layne W.W., Childs R.L. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:1982;327-332.
22. Mukai T., Arano Y., Nishida K., Sasaki H., Saji H., Nakamura J. In vivo evaluation of Indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice. J. Pharm. Pharmacol. 51:1999;15-20.
23. 125I. Effect of labelling on distribution and excretion of radioactivity in rats. J. Pharm. Sci. 88:1999;577-585.
24. Smith P.R., Thornalley P.J. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N-epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine. Eur. J. Biochem. 210:1992;729-739.
25. Heyes M.P., Chen C.Y., Major E.O., Saito K. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326:1997;351-356.
26. Sreelakshmi Y., Sharma K.K. Interaction of alpha-lactalbumin with mini alphaA-crystallin. J. Protein Chem. 20:2001;123-130.
27. Anraku M., Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm. Res. 18:2001;632-639.
28. Petersen C.E., Ha C.E., Curry S., Bhagavan N.V. Probing the structure of the warfarin-binding site on human serum albumin using site-directed mutagenesis. Proteins. 47:2002;116-125.
29. Ahmed N., Thornalley P.J. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem. J. 364:2002;15-24.
30. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344:1999;109-116.
31. Watanabe H., Tanase S., Nakajou K., Maruyama T., Kragh-Hansen U., Otagiri M. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem. J. 349:2000;813-819.
32. Okabe N., Hashizume N. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol. Pharm. Bull. 17:1994;16-21.
33. Bohney J.P., Feldhoff R.C. Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin. Biochem. Pharmacol. 43:1992;1829-1834.
34. Baynes J.W., Thorpe S.R. Identification of the sites of albumin catabolism in the rat. Arch. Biochem. Biophys. 206:1981;372-379.
35. Smedsrod B., Melkko J., Araki N., Sano H., Horiuchi S. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal, Kupffer and endothelial cells. Biochem. J. 322:1997;567-573.
36. Christensen E.I., Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am. J. Physiol., Renal Physiol. 280:2001;F562-F573.
37. Abiko A., Eto M., Makino I., Araki N., Horiuchi S. Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay. Metabolism. 49:2000;567-573.
38. Wu V.Y., Shearman C.W., Cohen M.P. Identification of calnexin as a binding protein for Amadori-modified glycated albumin. Biochem. Biophys. Res. Commun. 284:2001;602-606.
39. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia. 44:2001;129-146.